Links between arterial and venous disease

Journal of Internal Medicine

Volumn 262, Issue 3, 2007, Pages 341-350

  Prandoni, P ^a,b  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

Atherosclerosis; Deep vein thrombosis; Pulmonary embolism; Risk factors; Venous thromboembolism

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TAMOXIFEN;

ACUTE HEART INFARCTION; AGE DISTRIBUTION; ARTERY DISEASE; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD CLOTTING; BRAIN ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SMOKING; SUDDEN DEATH; VEIN DISEASE; VENOUS CIRCULATION; VENOUS THROMBOEMBOLISM;

EID: 34547851176     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2007.01815.x     Document Type: Review

References (61)

1. Singer DE, Albers GW, Dalen JE, Go AS, Halperin JL, Manning WJ. Antithrombotic therapy in atrial fibrillation: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004 126: 429 56S.
2. Harrington RA, Becker RC, Ezekowitz M et al. Antithrombotic therapy for coronary artery disease: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004 126: 513 48S.
3. Antithrombotic Trialist's Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. Br Med J 2002 324: 71 86.
4. Hovens MM, Snoep JD, Tamsma JT, Huisman MV. Aspirin in the prevention and treatment of venous thromboembolism. J Thromb Haemost 2006 4: 1470 5.
5. Janssen MC, den Heijer M, Cruysberg JR, Wollersheim H, Bredie SJ. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost 2005 93: 1021 6.
6. Tsaloumas MD, Kirwan J, Vinall H et al. Nine year follow-up study of morbidity and mortality in retinal vein occlusion. Eye 2000 14: 821 7.
7. Prandoni P, Bilora F, Marchiori A et al. An association between atherosclerosis and venous thrombosis. N Engl J Med 2003 348: 1435 41.
8. Prandoni P, Lensing AWA, Cogo A et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996 125: 1 7.
9. Prandoni P, Villalta S, Bagatella P et al. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. Haematologica 1997 82: 423 8.
10. Schulman S, Rhedin AS, Lindmarker P et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 1995 332: 1661 5.
11. Schulman S, Lindmarker P, Holmstrom M et al. Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost 2006 4: 734 42.
12. Prandoni P, Noventa F, Ghirarduzzi A et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1626 patients. Haematologica 2007 91: 199 205.
13. Heit J. Venous thromboembolism epidemiology: implications for prevention and management. Sem Thromb Hemost 2002 28 (Suppl. 2 3 13.
14. Cogo A, Bernardi E, Prandoni P et al. Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. Arch Intern Med 1994 154: 164 8.
15. Libertiny G, Hands L. Deep venous thrombosis in peripheral vascular disease. Br J Surg 1999 86: 907 10.
16. Goldhaber SZ, Grodstein F, Stampfer MJ et al. A prospective study of risk factors for pulmonary embolism in women. JAMA 1997 277: 642 5.
17. Hansson PO, Eriksson H, Welin L, Svardsudd K, Wilhelmsen L. Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: ''the study of men born in 1913''. Arch Intern Med 1999 159: 1886 90.
18. Stein PD, Beemath A, Olson RE. Obesity as a risk factor in venous thromboembolism. Am J Med 2005 118: 978 80.
19. Petrauskiene V, Falk M, Waernbaum I, Norberg M, Eriksson JW. The risk of venous thromboembolism is markedly elevated in patients with diabetes. Diabetologia 2005 48: 1017 21.
20. Hong C, Zhu F, Du D, Pilgram TK, Sicard GA, Bae KT. Coronary artery calcification and risk factors for atherosclerosis in patients with venous thromboembolism. Atherosclerosis 2005 183: 169 74.
21. Vormittag R, Vukovich T, Stain M, Lehr S, Minar E, Pabinger I. Lipoprotein(a) in patients with spontaneous venous Thromboembolism. Thromb Res 2006 (in press).
22. Vaya A, Mira Y, Ferrando F et al. Hyperlipidaemia and venous thromboembolism in patients lacking thrombophilic risk factors. Br J Haematol 2002 118: 255 9.
23. Marcucci R, Liotta AA, Cellai AP et al. Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism. Am J Med 2003 115: 601 5.
24. Deguchi H, Pecheniuk NM, Elias DJ, Averell PM, Griffin JH. High-density lipoprotein deficiency and dyslipoproteinemia associated with venous thrombosis in men. Circulation 2005 112: 893 9.
25. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thromboembolism incidence. Arch Intern Med 2002 162: 1182 9.
26. Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol 2005 162: 975 82.
27. Decensi A, Maisonneuve P, Rotmensz N et al. Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial. Circulation 2005 111: 650 6.
28. Ageno W, Prandoni P, Romualdi E et al. The metabolic syndrome and the risk of venous thrombosis. A prospective, case control study. J Thromb Haemost 2006 4: 1914 8.
29. Eliasson A, Bergqvist D, Bjorck M, Acosta S, Sternby NH, Ogren M. Prevalence and risk of venous thromboembolism in patients with verified arterial thrombosis: a population study based on 23 796 consecutive autopsies. J Thromb Haemost 2006 4: 1897 902.
30. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984 311: 501 5.
31. Meade TW, Mellows S, Brozovic M et al. Haemostatic function and ischemic heart disease: principal results from the Northwick Park Heart Study. Lancet 1986 2: 533 7.
32. Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 1995 332: 635 41.
33. Miller GJ, Bauer KA, Barzegar S, Cooper JA, Rosenberg RD. Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease. Thromb Haemost 1996 75: 767 71.
34. Folsom AR, Wu KK, Rosamond WR, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1997 96: 1102 8.
35. Folsom AR, Aleksic N, Park E, Salomaa V, Juneja H, Wu KK. Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol 2001 21: 611 7.
36. Koenig W, Rothenbacher D, Hoffmeister A, Griesshammer M, Brenner H. Plasma fibrin D-dimer levels and risk of stable coronary artery disease: results of a large case-control study. Arterioscler Thromb Vasc Biol 2001 21: 1701 5.
37. Strano A, Hoppensteadt D, Walenga JM et al. Plasma levels of the molecular markers of coagulation and fibrinolysis in patients with peripheral arterial disease. Semin Thromb Hemost 1996 22 (Suppl. 1 35 40.
38. De Buyzere M, Philippe J, Duprez D, Baele G, Clement DL. Coagulation system activation and increased D-dimer levels in peripheral arterial occlusive disease. Am J Hematol 1993 43: 91 4.
39. Lowe GD, Fowkes FG, Dawes J, Donnan PT, Lennie SE, Housley E. Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation 1993 87: 1915 20.
40. Guthikonda S, Haynes WG. Homocysteine: role and implications in atherosclerosis. Curr Atheroscler Rep 2006 8: 100 6.
41. Oger E, Lacut K, Le Gal G et al. Hyperhomocysteinemia and low B vitamin levels are independently associated with venous thromboembolism: results from the EDITH study: a hospital-based case-control study. J Thromb Haemost 2006 4: 793 9.
42. Gaudstadnes M, Rudiger N, Moller J et al. Thrombophilic predisposition in stroke and venous thromboembolism in Danish patients. Blood Coagul Fibrinolysis 1999 10: 251 9.
43. Ye Z, Liu EHC, Higgins JPT et al. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66 155 cases and 91 307 controls. Lancet 2006 367: 651 8.
44. Foley PW, Irvine CD, Standen GR et al. Activated protein C, factor V Leiden and peripheral vascular disease. Cardiovasc Surg 1997 5: 157 60.
45. Erkan D, Lockshin MD. Antiphospholipid syndrome. Curr Opin Rheumatol 2006 18: 242 8.
46. Bank I, Libourel EJ, Middeldorp S et al. Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis. J Thromb Haemost 2005 3: 79 84.
47. Michiels JJ, Berneman Z, Van Bockstaele D, van der Planken M, De Raeve H, Schroyens W. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications. Semin Thromb Hemost 2006 32: 174 207.
48. Levine MN. Prevention of thrombotic disorders in cancer patients undergoing chemotherapy. Thromb Haemost 1997 78: 133 6.
49. Omine M, Kinoshita T, Nakakuma H, Maciejewski JP, Parker CJ, Socie G. Paroxysmal nocturnal hemoglobinuria. Int J Hematol 2005 82: 417 21.
50. Maraha B, Peeters MF, van Aken BE, den Heijer M. Chlamydia pneumoniae, systemic inflammation and the risk of venous thrombosis. Diagn Microbiol Infect Dis 2002 42: 153 7.
51. Lijfering WM, ten Cate MK, Sprenger HG, van der Meer J. Absolute risk of venous and arterial thrombosis in HIV-infected patients and effects of combination antiretroviral therapy. J Thromb Haemost 2006 4: 1928 30.
52. Reich LM, Folsom AR, Key NS et al. Prospective study of subclinical atherosclerosis as a risk factor for venous thromboembolism. J Thromb Haemost 2006 4: 1909 13.
53. van der Hagen PB, Folsom AR, Jenny NS et al. Subclinical atherosclerosis and the risk of future venous thrombosis in the Cardiovascular Health Study. J Thromb Haemost 2006 4: 1903 8.
54. Becattini C, Agnelli G, Prandoni P et al. A prospective study on cardiovascular events after acute pulmonary embolism. Eur Heart J 2005 26: 77 83.
55. Prandoni P, Ghirarduzzi A, Prins MH et al. Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis. J Thromb Haemost 2006 4: 1891 6.
56. Bova C, Marchiori A, Noto A et al. Incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism. A retrospective cohort study. Thromb Haemost 2006 96: 132 6.
57. Young L, Ockelford P, Milne D, Rolfe-Vyson V, McKelvie S, Harper P. Post treatment residual thrombus increases the risk of recurrent deep vein thrombosis and mortality. J Thromb Haemost 2006 4: 1919 24.
58. Prandoni P, Lensing AWA, Prins MH et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med 2002 137: 985 90.
59. Steffen LM, Folsom AR, Cushman M, Jacobs DR Jr., Rosamond WD. Greater fish, fruit, and vegetable intakes are related to lower incidence of venous thromboembolism. The longitudinal investigation of thromboembolism etiology. Circulation 2006 115: 188 95.
60. Squizzato A, Romualdi E, Ageno W. Why should statins prevent venous thromboembolism? A systematic literature search and a call for action. J Thromb Haemost 2006 4: 1925 7.
61. Agnelli G, Becattini C. Venous thromboembolism and atherosclerosis: common denominators or different diseases J Thromb Haemost 2006 4: 1886 90.